NEK2 regulates cellular proliferation and cabergoline sensitivity in pituitary adenomas

Conclusions: Collectively, our results suggest that NEK2 might be a potential therapeutic target for prolactinoma.

Source: Journal of Cancer - April 19, 2021 Category: Cancer & Oncology Authors: Fangfang Jian, Yuhao Sun, Qingfang Sun, Benyan Zhang, Liuguan Bian Tags: Research Paper Source Type: research